Atara Biotherapeutics, Inc
Symbol: ATRA (NASDAQ)
14.26
▼ (-0.49%) -0.070
Company Description:
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).
Key Stats
- Today's Open: $14.26
- Today's High: $14.26
- Today's Low: $14.26
- Today's Volume: 51
- Yesterday Close: $14.33
- Yesterday High: $14.5699
- Yesterday Low: $13.12
- Yesterday Volume: 89.56K
- Last Min Volume: 39
- Last Min High: $14.26
- Last Min Low: $14.26
- Last Min VWAP: $14.26
Company Profile
- Name: Atara Biotherapeutics, Inc
- Website: https://www.atarabio.com
- Listed Date: 2014-10-16
- Location: THOUSAND OAKS, CA
- Market Status: Active
- CIK Number: 0001604464
- SIC Code: 2836
- SIC description: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
- Market Cap: $100.64M
- Round Lot: 100
- Outstanding Shares: 7.02M
- Asset Type: CS
RECENT FILINGS FOR ATRA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-04 | 8-K | View |
| 2025-08-20 | 4 | View |
| 2025-08-20 | 4 | View |
| 2025-08-19 | 4 | View |
| 2025-08-19 | SCHEDULE 13D/A | View |
| 2025-08-18 | 144 | View |
| 2025-08-18 | 144 | View |
| 2025-08-11 | 10-Q | View |
| 2025-08-11 | 8-K | View |
| 2025-07-21 | 4 | View |
| 2025-07-14 | 8-K | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-12 | 4 | View |
| 2025-06-11 | 8-K | View |
| 2025-05-23 | SCHEDULE 13D | View |
| 2025-05-23 | 3 | View |
Latest News on ATRA